Cancer Treatment Pharmaceutical Combination Patent - Johannes Gutenberg-Universität Mainz
Summary
The European Patent Office published application EP3790582A1 for a pharmaceutical combination for use in cancer treatment, filed by Universitätsmedizin der Johannes Gutenberg-Universität Mainz. Inventors include Rosigkeit, Bockamp, and Schuppan, with IPC classifications covering therapeutic antibodies (C07K 16/28), immunomodulators (A61K 39/395, A61K 39/39), and antisense compounds (C12N 15/117). The patent application was published on April 15, 2026.
“A PHARMACEUTICAL COMBINATION FOR USE IN THE TREATMENT OF CANCER”
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 34 changes logged to date.
What changed
The EPO published European patent application EP3790582A1 for a pharmaceutical combination directed to cancer treatment (A61P 35/00). The application claims combinations including therapeutic antibodies, immunological adjuvants, and antisense nucleic acids.
For parties in the pharmaceutical and biotechnology sectors, this patent grant establishes intellectual property rights in the designated contracting states (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR). Freedom-to-operate analyses for cancer therapies in these territories should account for this publication.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
A PHARMACEUTICAL COMBINATION FOR USE IN THE TREATMENT OF CANCER
Publication EP3790582A1 Kind: A1 Apr 15, 2026
Applicants
Universitätsmedizin der
Johannes Gutenberg-Universität Mainz
Inventors
ROSIGKEIT, Sebastian, BOCKAMP, Ernst-Otto, SCHUPPAN, Detlev
IPC Classifications
A61K 39/395 20060101AFI20191115BHEP A61K 39/39 20060101ALI20191115BHEP C07K 16/28 20060101ALI20191115BHEP C12N 15/117 20100101ALI20191115BHEP A61P 35/00 20060101ALI20191115BHEP A61K 39/00 20060101ALI20191115BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.